OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase I study of dasatinib (BMS‐354825) in Japanese patients with solid tumors

HTML

Year: 2011
Type: article
Study design: Clinical Trial
Source: Cancer Science
DOI: 10.1111/j.1349-7006.2011.02041.x
Authors: Shunji Takahashi, Masaki Miyazaki, Isamu Okamoto, Yoshinori Ito, Kyoji Ueda, Taku Seriu, Kazuhiko Nakagawa, Kiyohiko Hatake
Institutions: The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Kindai University Hospital, Kindai University, Bristol-Myers Squibb (Japan)
Language: English

Topic: Cancer Mechanisms and Therapy
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: dasatinib, Src family kinases, tyrosine kinase inhibitors, solid tumors, refractory cancer, maximum tolerated dose, dose-limiting toxicity, pleural effusion, pharmacokinetics, pharmacodynamics, bone resorption markers, NTX, TRACP-5b, anticancer activity, Japanese patients
SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Pfizer, Sanofi, Ono Pharmaceutical, Chugai Pharmaceutical, Japan Society for the Promotion of Science
Award: Elucidation of interaction between bone marrow micro-metastases in breast cancer patients
OpenAlex ID: W2000350300
FWCI: 0.679
Cites: 36
Cited by: 25
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security